Literature DB >> 14967220

Pre-eclampsia: associated with increased syncytial apoptosis when the infant is small-for-gestational-age.

Rigmor Austgulen1, Christina Vogt Isaksen, Lisa Chedwick, Pål Romundstad, Lars Vatten, Catherine Craven.   

Abstract

The present investigation was undertaken to study the association between placental apoptosis and pre-eclampsia, discriminating between pre-eclamptic pregnancies with appropriate-, and small-for-gestational-age (SGA), infants. Twenty pregnancies with pre-eclampsia and SGA (birth weight at or below -2 standard deviations) infants were selected in a retrospective study. Subsequently, corresponding numbers of gestational age-matched pre-eclampsia cases with appropriate-gestational-age (AGA) (birth weight at or above the 50% centile) infants and AGA controls without pre-eclampsia were selected. Formalin-fixed placental tissue was obtained from all groups. Apoptosis was assessed by a monoclonal antibody (M30), detecting a neoepitope of cytokeratin that is generated early in the apoptotic cascade. M30-positive cells were counted in villous and decidual/ basal plate tissue fields, and results were given as numbers of M30-positive cells per field. The study was performed blinded. Increased apoptosis was found in the syncytiotrophoblast layer in pre-eclampsia with SGA infants (0.14 apototic incidents per field of villous tissue, with 0.04-0.23 as the corresponding 25-75% inter quartile range (IQR) (P=0.05)). Syncytial apoptosis in the syncytial layer in the pre-eclampsia group with AGA infants was lower (0.09, IQR 0.03-0.15) and corresponded to the level detected among controls (0.06, IQR 0.03-0.17). Apoptosis in other placental cellular compartments did not differ between groups. The increased syncytial apoptosis found in placentas from pregnancies with SGA infants may either be due to specific mechanisms associated with pre-eclampsia complicated with growth restriction, or may simply reflect the presence of syncytiotrophoblast layer damage, regardless of underlying pathological condition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14967220     DOI: 10.1016/j.jri.2003.10.001

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  9 in total

1.  E-cadherin in the assessment of aberrant placental cytotrophoblast turnover in pregnancies complicated by pre-eclampsia.

Authors:  L M Brown; H A Lacey; P N Baker; I P Crocker
Journal:  Histochem Cell Biol       Date:  2005-09-02       Impact factor: 4.304

2.  Reduced syncytin-1 expression in choriocarcinoma BeWo cells activates the calpain1-AIF-mediated apoptosis, implication for preeclampsia.

Authors:  Qiang Huang; Haibin Chen; Fengchao Wang; Brian C Brost; Jinping Li; Yu Gao; Zongfang Li; Ya Gao; Shi-Wen Jiang
Journal:  Cell Mol Life Sci       Date:  2014-01-12       Impact factor: 9.261

3.  Should bilateral uterine artery notching be used in the risk assessment for preeclampsia, small-for-gestational-age, and gestational hypertension?

Authors:  Jimmy Espinoza; Juan Pedro Kusanovic; Ray Bahado-Singh; Maria Teresa Gervasi; Roberto Romero; Wesley Lee; Edi Vaisbuch; Shali Mazaki-Tovi; Pooja Mittal; Francesca Gotsch; Offer Erez; Ricardo Gomez; Lami Yeo; Sonia S Hassan
Journal:  J Ultrasound Med       Date:  2010-07       Impact factor: 2.153

4.  Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor.

Authors:  Jimmy Espinoza; Roberto Romero; Jyh Kae Nien; Ricardo Gomez; Juan Pedro Kusanovic; Luis F Gonçalves; Luis Medina; Sam Edwin; Sonia Hassan; Mario Carstens; Rogelio Gonzalez
Journal:  Am J Obstet Gynecol       Date:  2007-04       Impact factor: 8.661

Review 5.  A stereological perspective on placental morphology in normal and complicated pregnancies.

Authors:  Terry M Mayhew
Journal:  J Anat       Date:  2008-01-02       Impact factor: 2.610

6.  A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Edi Vaisbuch; Shali Mazaki-Tovi; Francesca Gotsch; Samuel S Edwin; Ricardo Gomez; Lami Yeo; Agustin Conde-Agudelo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

Review 7.  Morphological changes of placental syncytium and their implications for the pathogenesis of preeclampsia.

Authors:  Cynthia S Roland; Jian Hu; Chun-E Ren; Haibin Chen; Jinping Li; Megan S Varvoutis; Lynn W Leaphart; David B Byck; Xueqiong Zhu; Shi-Wen Jiang
Journal:  Cell Mol Life Sci       Date:  2015-10-26       Impact factor: 9.261

Review 8.  Intrauterine growth restriction, human placental development and trophoblast cell death.

Authors:  Christina M Scifres; D Michael Nelson
Journal:  J Physiol       Date:  2009-05-18       Impact factor: 5.182

Review 9.  Gene expression in the placenta: maternal stress and epigenetic responses.

Authors:  Ciprian P Gheorghe; Ravi Goyal; Ashwani Mittal; Lawrence D Longo
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.